VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,701 | -37.6% | 97,616 | -4.8% | 0.13% | -23.8% |
| Q2 2023 | $675,660 | -19.6% | 102,528 | -17.2% | 0.17% | -58.7% |
| Q1 2023 | $840,582 | -16.6% | 123,797 | -9.2% | 0.42% | +11.5% |
| Q4 2022 | $1,007,442 | -79.1% | 136,325 | -72.1% | 0.37% | -75.7% |
| Q3 2022 | $4,831,000 | -9.4% | 488,965 | 0.0% | 1.54% | -23.3% |
| Q2 2022 | $5,330,000 | +190.0% | 488,965 | +200.9% | 2.00% | +229.3% |
| Q1 2022 | $1,838,000 | -9.1% | 162,478 | -22.3% | 0.61% | +52.0% |
| Q3 2020 | $2,021,000 | +22.6% | 209,205 | +45.2% | 0.40% | -16.8% |
| Q2 2020 | $1,649,000 | -77.9% | 144,114 | -80.0% | 0.48% | -80.8% |
| Q1 2020 | $7,472,000 | – | 721,193 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |